Home › Mutual Funds › UTI Mutual Fund › UTI Healthcare Fund-Growth Option- Direct
Latest NAV & returns of UTI ASSET MANAGEMENT COMPANY LTD.

UTI Healthcare Fund-Growth Option- Direct

Add To Compare

previously known as UTI Pharma & Healthcare Dir Gr until

250.127 (0.301%)
NAV on May 15, 2024
Category Equity:
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets 943 cr
Turnover Ratio 43.40%
Expense Ratio 1.35%
Exit Load 1.00%if redeemed within
30 Days0.00%if redeemed after 30 Days
Returns
  • 1M: 0.69%
  • 1Y: 51.12%
  • 3M: 0.80%
  • 3Y: 13.76%
  • 6M: 18.76%
  • 5Y: 23.69%
Min Investment 5,000
Buy Now Start SIP
ADDITIONAL INFO
Fund Manager Kamal Gada (Since about 2 years)
ISIN INF789F01TO9
Fund Family UTI
P/E Ratio 38.17
P/B Ratio 5.58
Launch Date January 01, 2013
Benchmark S&P BSE Healthcare TR INR
ASSET ALLOCATION
EQUITY DISTRIBUTION
RISK MEASURES (3 yrs)
vs S&P BSE Healthcare TR INR

Alpha 0.35
Beta 0.93
R-Squared 95.75
Info Ratio -0.10
Tracking Err 3.15
Sortino 1.144
Sharpe 0.676
Std Dev 14.409
Risk -
SECTOR WEIGHTINGS (%)
Financial 0.62%
Industrial 0.0%
Technology 0.0%
Basic Materials 1.37%
Consumer Cyclical 0.0%
Utilities Services 0.0%
Healthcare Services 98.02%
Energy Services 0.00%
Communication Services 0.00%
Consumer Defensive 0.00%
Real Estate 0.00%
INVESTMENT OBJECTIVE

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

You will not receive any dividends. Your investments will get the largest benefit of compounding.

View Factsheet
-
Best Arbitrage Fund Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Quant
Quant Healthcare Fund Direct Growth
13.739 — 279 cr 0.68% -
Best Sector Healthcare Funds
NAME LATEST
NAV		 RETURNS
1y     		FUND
ASSETS		 Expense
RATIO		 RISK
Icici
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct Growth
32.650 56.46% 3,835 cr 1.04% -
Tata
Tata India Pharma & Healthcare Fund Direct Growth
28.817 53.76% 894 cr 0.84% -
Sbi
SBI Healthcare Opportunities Fund Direct Growth
390.534 52.96% 2,667 cr 0.95% -
Reliance
Nippon India Pharma Fund - Direct Plan - Growth Plan
474.303 52.10% 7,133 cr 0.92% -


Other plans of UTI Healthcare


Other Equity funds by UTI

Data Partner
Click here to visit AMC website and
read all scheme related documents UTI Fund